GENE ONLINE|News &
Opinion
Blog

2022-04-15| In-Depth

New Approaches to Effectively Manage Hemophilia in Pregnant Women

by Arvind C. Shekhar
Share To
Hemophilia is a X-linked hereditary bleeding disorder characterized by an absent or decreased coagulation factor VIII (FVIII) in Hemophilia A (HA) or factor IX (FIX) in the case of Hemophilia B (HB). Caused due to a recessive X-chromosomal inheritance pattern, mostly men are affected while their female relatives generally serve as carriers of hemophilia. In terms of numbers, the prevalence of hemophilia is approximately 1 in 5000 males.

It's free! Log in now to read

LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top